Scientific Program

08:00
Registration
09:00
How I manage large granular cell leukemia
Renato Zambello

Hematology at the Department of Medicine, University of Padova, Italy
09:30
Front-line treatment in Chronic Lymphocytic Leukemia (CLL)
Talha Munir
St. James’s University Hospital, Leeds, UK
09:50
Practical management of Chronic Lymphocytic Leukemia (CLL) patients treated with novel agents
Lydia Scarfò

Department of Onco-Hematology, San Raffaele Scientific Institute, Italy
10:10
Management of Chronic Lymphocytic Leukemia (CLL) in countries with low-income economy
Jean El-Cheikh

American University of Beirut Medical Center, Lebanon
11:00
Allo-SCT 3.0 in the Elderly: towards new eligibility criteria and tailored conditioning platforms
Michele Malagola

Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Italy
11:30
New insights on immune reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): microbiome and Cytomegalovirus (CMV) specific responses
Raffaela Greco

IRCCS San Raffaele Hospital, Milano, Italy
12:00
Maintenance therapy post allogeneic transplant in Acute Myeloid Leukemia (AML)
Jean El-Cheikh

American University of Beirut Medical Center, Lebanon
13:30
Philadelphia positive Acute Myeloid Leukemia (ALL)
Oliver Ottmann
Haematology Division of Cancer and Genetics, Cardiff University, UK
14:00
Monoclonal antibodies: the gamechangers in Acute lymphoblastic leukema (pre-recorded)
Claudio Cerchione

Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Italy
14:30
How I treat Chronic Myeloid Leukemia (CML) in 2022
Giuseppe Saglio
Hematology & Internal Medicine, University of Turin, Italy